These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 18422740)

  • 41. Nephron-sparing surgery for renal cell carcinoma: clinicopathologic features predictive of patient outcome.
    Krejci KG; Blute ML; Cheville JC; Sebo TJ; Lohse CM; Zincke H
    Urology; 2003 Oct; 62(4):641-6. PubMed ID: 14550434
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The clinical significance of PYCR1 expression in renal cell carcinoma.
    Weijin F; Zhibin X; Shengfeng Z; Xiaoli Y; Qijian D; Jiayi L; Qiumei L; Yilong C; Hua M; Deyun L; Jiwen C
    Medicine (Baltimore); 2019 Jul; 98(28):e16384. PubMed ID: 31305441
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum level of ANGPTL4 as a potential biomarker in renal cell carcinoma.
    Dong D; Jia L; Zhou Y; Ren L; Li J; Zhang J
    Urol Oncol; 2017 May; 35(5):279-285. PubMed ID: 28110976
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Decreased selenium-binding protein 1 mRNA expression is associated with poor prognosis in renal cell carcinoma.
    Ha YS; Lee GT; Kim YH; Kwon SY; Choi SH; Kim TH; Kwon TG; Yun SJ; Kim IY; Kim WJ
    World J Surg Oncol; 2014 Sep; 12():288. PubMed ID: 25227434
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The platelet to lymphocyte ratio predicts overall survival better than the neutrophil to lymphocyte ratio in metastatic renal cell carcinoma.
    Aktepe OH; Güner G; Güven DC; Şahin TK; Ardıç FS; Yüce D; Yalçın Ş; Erman M
    Turk J Med Sci; 2021 Apr; 51(2):757-765. PubMed ID: 33350295
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Renal Cell Carcinoma with Isolated Lymph Node Involvement: Long-term Natural History and Predictors of Oncologic Outcomes Following Surgical Resection.
    Gershman B; Moreira DM; Thompson RH; Boorjian SA; Lohse CM; Costello BA; Cheville JC; Leibovich BC
    Eur Urol; 2017 Aug; 72(2):300-306. PubMed ID: 28094055
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic significance of serum albumin in patients with metastatic renal cell carcinoma.
    Stenman M; Laurell A; Lindskog M
    Med Oncol; 2014 Mar; 31(3):841. PubMed ID: 24477648
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic factors for survival in metastatic renal cell carcinoma: retrospective analysis from 109 consecutive patients.
    Citterio G; Bertuzzi A; Tresoldi M; Galli L; Di Lucca G; Scaglietti U; Rugarli C
    Eur Urol; 1997; 31(3):286-91. PubMed ID: 9129917
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Validation of circulating MMP-7 level as an independent prognostic marker of poor survival in urinary bladder cancer.
    Szarvas T; Jäger T; Becker M; Tschirdewahn S; Niedworok C; Kovalszky I; Rübben H; Ergün S; vom Dorp F
    Pathol Oncol Res; 2011 Jun; 17(2):325-32. PubMed ID: 21253919
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Circulating matrix metalloproteinase-7: an early or metastatic marker for renal cell carcinoma?
    Jung K; Ramankulov A; Schrader M; Miller K; Lein M
    Clin Chem; 2008 Nov; 54(11):1927-9. PubMed ID: 18957565
    [No Abstract]   [Full Text] [Related]  

  • 51. Preoperative Neutrophil to Lymphocyte Ratio as a Prognostic Factor in Patients with Non-metastatic Renal Cell Carcinoma.
    Wen RM; Zhang YJ; Ma S; Xu YL; Chen YS; Li HL; Bai J; Zheng JN
    Asian Pac J Cancer Prev; 2015; 16(9):3703-8. PubMed ID: 25987025
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Extent of lymph node dissection at nephrectomy affects cancer-specific survival and metastatic progression in specific sub-categories of patients with renal cell carcinoma (RCC).
    Capitanio U; Suardi N; Matloob R; Roscigno M; Abdollah F; Di Trapani E; Moschini M; Gallina A; Salonia A; Briganti A; Montorsi F; Bertini R
    BJU Int; 2014 Aug; 114(2):210-5. PubMed ID: 24854206
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical T1/2 renal cell carcinoma: multiparametric dynamic contrast-enhanced MRI features-based model for the prediction of individual adverse pathology.
    Wang K; Guo B; Yao Z; Li G
    World J Surg Oncol; 2024 Jun; 22(1):145. PubMed ID: 38822338
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of the 2002 and 2010 TNM classification systems regarding outcome prediction in clear cell and papillary renal cell carcinoma.
    Pichler M; Hutterer GC; Chromecki TF; Jesche J; Kampel-Kettner K; Groselj-Strele A; Hoefler G; Pummer K; Zigeuner R
    Histopathology; 2013 Jan; 62(2):237-46. PubMed ID: 23020176
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development and validation of a nomogram to predict overall survival for patients with metastatic renal cell carcinoma.
    Zheng W; Zhu W; Yu S; Li K; Ding Y; Wu Q; Tang Q; Zhao Q; Lu C; Guo C
    BMC Cancer; 2020 Nov; 20(1):1066. PubMed ID: 33148204
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of survival outcomes in patients with metastatic papillary vs. clear-cell renal cell carcinoma: a propensity-score analysis.
    Rosiello G; Palumbo C; Knipper S; Pecoraro A; Luzzago S; St-Hilaire PA; Tian Z; Capitanio U; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI
    World J Urol; 2021 Feb; 39(2):461-472. PubMed ID: 32253579
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Effect of Preoperative Apolipoprotein A-I on the Prognosis of Surgical Renal Cell Carcinoma: A Retrospective Large Sample Study.
    Guo S; He X; Chen Q; Yang G; Yao K; Dong P; Ye Y; Chen D; Zhang Z; Qin Z; Liu Z; Li Z; Xue Y; Zhang M; Liu R; Zhou F; Han H
    Medicine (Baltimore); 2016 Mar; 95(12):e3147. PubMed ID: 27015197
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Histologic tumor necrosis is an independent prognostic indicator for clear cell and papillary renal cell carcinoma.
    Pichler M; Hutterer GC; Chromecki TF; Jesche J; Kampel-Kettner K; Rehak P; Pummer K; Zigeuner R
    Am J Clin Pathol; 2012 Feb; 137(2):283-9. PubMed ID: 22261455
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic implications of sarcomatoid and rhabdoid differentiation in patients with grade 4 renal cell carcinoma.
    Kara O; Maurice MJ; Zargar H; Malkoc E; Akca O; Andrade HS; Ramirez D; Caputo PA; Nelson RJ; Rini B; Kaouk JH
    Int Urol Nephrol; 2016 Aug; 48(8):1253-1260. PubMed ID: 27215555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.